Amplification of chromosomal segment 4q12 in non-small cell lung cancer
Open Access
- 1 November 2009
- journal article
- Published by Informa UK Limited in Cancer Biology & Therapy
- Vol. 8 (21), 2042-2050
- https://doi.org/10.4161/cbt.8.21.9764
Abstract
In cancer, proto-oncogenes are often altered by genomic amplification. Here we report recurrent focal amplifications of chromosomal segment 4q12 overlapping the proto-oncogenes PDGFRA and KIT in non-small cell lung cancer (NSCLC). Single nucleotide polymorphism (SNP) array and fluorescent in situ hybridization (FISH) analysis indicate that 4q12 is amplified in 3–7% of lung adenocarcinomas and 8–10% of lung squamous cell carcinomas. In addition, we demonstrate that the NSCLC cell line NCI-H1703 exhibits focal amplification of PDGFRA and is dependent on PDGFRα activity for cell growth. Treatment of NCI-H1703 cells with PDGFRA-specific shRNAs or with the PDGFRα/KIT small molecule inhibitors imatinib or sunitinib leads to cell growth inhibition. However, these observations do not extend to NSCLC cell lines with lower-amplitude and broader gains of chromosome 4q. Together these observations implicate PDGFRA and KIT as potential oncogenes in NSCLC, but further study is needed to define the specific characteristics of those tumors that could respond to PDGFRα/KIT inhibitors.Keywords
This publication has 43 references indexed in Scilit:
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- TTF1 expression in non‐small cell lung carcinoma: association with TTF1 gene amplification and improved survivalThe Journal of Pathology, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- PIK3CA Mutations and Copy Number Gains in Human Lung CancersCancer Research, 2008
- Drug-sensitiveFGFR2mutations in endometrial carcinomaProceedings of the National Academy of Sciences, 2008
- DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancersOncogene, 2008
- Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsProceedings of the National Academy of Sciences of the United States of America, 2006
- Polyclonal Evolution of Multiple Secondary KIT Mutations in Gastrointestinal Stromal Tumors under Treatment with Imatinib MesylateClinical Cancer Research, 2006
- A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content ScreenCell, 2006
- Common and Contrasting Genomic Profiles among the Major Human Lung Cancer SubtypesPublished by Cold Spring Harbor Laboratory ,2005